StoryNote
Log in
|
Sign up
/u/Professional_Disk131's
posts in
/r/Wealthsimple_Penny
Year:
All
2024
Show search filters
Search by title:
Hide posts already read
Only show posts with narrations
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma (TSXV: NRX, OTCQB: NRXBF)
2 upvotes
Mark as read:
--
10
9
8
7
6
5
4
3
2
1
0
Add to a list
NurExone Biologics: Promising Future in Regenerative Medicine
1 upvotes
Mark as read:
--
10
9
8
7
6
5
4
3
2
1
0
Add to a list
Title
Upvotes
Mark as read
Favorited
Rating
Add to a list
Promising Preliminary Results in Optic Nerve Recovery Study of NurExone’s first product ExoPTEN for Glaucoma (TSXV: NRX, OTCQB: NRXBF)
2
--
10
9
8
7
6
5
4
3
2
1
0
NurExone Biologics: Promising Future in Regenerative Medicine
1
--
10
9
8
7
6
5
4
3
2
1
0
«
<
>
»
Page
of 1
Go
